Company Comparison
BioFlow Dynamics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | BioFlow Dynamics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Boston | South San Francisco, California |
| Founded | — | 2006 |
| Status | Active | Active |
| Last Funding Stage | Series A | — |
| Total Funding | $32M | — |
| Valuation | — | — |
What They Build
BioFlow Dynamics
A Boston biotech company focused on biological flow systems and dynamics technologies, with $32M in Series A funding.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
BioFlow Dynamics
No investors listed.
Sector Overlap
Both BioFlow Dynamics and 23andMe operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.